Skip to content

Periosteal Stimulation for Knee Osteoarthritis

Efficacy of Periosteal Stimulation and Boosters for Advanced Knee OA Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00865046
Acronym
PST
Enrollment
190
Registered
2009-03-19
Start date
2009-11-30
Completion date
2013-09-30
Last updated
2015-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Keywords

acupuncture

Brief summary

185 veterans with chronic knee pain and advanced knee osteoarthritis will be recruited to participate in this study designed to test the effectiveness of a special type of electrical acupuncture called periosteal stimulation (PST). Participants will be divided into three groups. They will receive PST or a control condition once a week for 10 weeks. Two-thirds of the participants will receive booster sessions periodically over the course of the next 6 months. Everyone will be called monthly during the 6 month period and then will be asked to return for an evaluation on site at the end of this period.

Detailed description

We have performed a promising initial trial of periosteal stimulation (PST, that is, electrical stimulation of 4 acupuncture needles around the knee that touch periosteum) as an analgesic for older veterans with advanced knee osteoarthritis (OA) and daily pain. The primary aim of the proposed trial is to optimize and sustain the efficacy of PST for reducing pain in veterans with advanced knee OA and unrelieved pain by combining it with booster PST. Our secondary aims are to 1) improve physical performance in these individuals, and 2) ascertain the physical and psychological predictors of response to PST. In a randomized controlled clinical trial, 180 veterans (age 50 and older) with persistent knee pain who have x-ray evidence of advanced OA will be assigned to one of three intervention groups: 1) control PST once a week for 10 weeks (i.e., needle placement with brief stimulation of non-periosteal needles), 2) PST once a week for 10 weeks followed by tapering PST boosters over 6 months, or 3) PST once a week for 10 weeks followed by tapering control-PST boosters over 6 months. Prior to initiating the intervention, immediately after the last session, and 6 months later, the following parameters will be assessed: 1) pain severity (WOMAC), 3) physical performance (gait velocity, stair climb, repetitive chair rise, timed up and go), and 4) psychological function (mood, coping, self-efficacy). Monthly telephone calls will assess pain, interim illness and physical activity.

Interventions

OTHERPeriosteal stimulation

Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.

OTHERControl-Periosteal Stimulation

Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
50 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* English speaking, * Knee pain on most days of the past 3 months that is more severe than pain in other parts of the lower body, * Advanced knee OA by x-ray, * age 50-89

Exclusion criteria

* Non-ambulatory or severely impaired mobility (i.e., require the use of a walker), * Folstein MMSE \< 24, * Severe uncorrected visual or hearing impairment, * Knee pain due to factors other than OA, * Large knee effusion, * History of corticosteroid or hyaluronic acid injection in the affected knee(s) during the preceding 3 months, * Acute or terminal illness, * Immune suppression, * Anticoagulation therapy, * Pacemaker, * Prior PST treatment * Active participation in other studies currently * Age \>89

Design outcomes

Primary

MeasureTime frameDescription
Pain (WOMAC)9 months following baselineThe Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales: Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)

Countries

United States

Participant flow

Participants by arm

ArmCount
Arm 1
PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.
63
Arm 2
PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.
64
Arm 3
control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.
63
Total190

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyDeath011
Overall StudyLost to Follow-up140
Overall StudyWithdrawal by Subject500

Baseline characteristics

CharacteristicArm 2TotalArm 3Arm 1
Age, Continuous65.8 years
STANDARD_DEVIATION 8.7
66.5 years
STANDARD_DEVIATION 9.3
66.8 years
STANDARD_DEVIATION 10.4
67.1 years
STANDARD_DEVIATION 8.9
Arthritis Self-Efficacy score, function76.3 units on a scale
STANDARD_DEVIATION 16.9
76.6 units on a scale
STANDARD_DEVIATION 16.8
76.1 units on a scale
STANDARD_DEVIATION 16.4
77.5 units on a scale
STANDARD_DEVIATION 17
Arthritis Self-Efficacy score, other symptoms65.9 units on a scale
STANDARD_DEVIATION 20.3
68.3 units on a scale
STANDARD_DEVIATION 20.8
68.6 units on a scale
STANDARD_DEVIATION 20.9
70.5 units on a scale
STANDARD_DEVIATION 21.1
Arthritis Self-Efficacy score, pain59.5 units on a scale
STANDARD_DEVIATION 22.6
62.6 units on a scale
STANDARD_DEVIATION 22
63.9 units on a scale
STANDARD_DEVIATION 21.7
64.3 units on a scale
STANDARD_DEVIATION 21.6
BMI33.1 kg/m2
STANDARD_DEVIATION 6.2
32.4 kg/m2
STANDARD_DEVIATION 6.5
32.5 kg/m2
STANDARD_DEVIATION 6.9
31.6 kg/m2
STANDARD_DEVIATION 6.5
CES-D14.7 units on a scale
STANDARD_DEVIATION 11.2
12.9 units on a scale
STANDARD_DEVIATION 10.4
12.3 units on a scale
STANDARD_DEVIATION 9.6
11.7 units on a scale
STANDARD_DEVIATION 10.3
Cognitive Strategies Questionnaire, catastrophizing scale12.1 units on a scale
STANDARD_DEVIATION 9.7
9.6 units on a scale
STANDARD_DEVIATION 8.9
8.8 units on a scale
STANDARD_DEVIATION 9.2
7.9 units on a scale
STANDARD_DEVIATION 7.8
Duration of knee pain6.2 years
STANDARD_DEVIATION 6.8
6.4 years
STANDARD_DEVIATION 7.2
7.2 years
STANDARD_DEVIATION 8.3
5.7 years
STANDARD_DEVIATION 6.4
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants2 Participants0 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
64 Participants188 Participants63 Participants61 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Mean number of opioids0.3 opioids
STANDARD_DEVIATION 0.6
0.2 opioids
STANDARD_DEVIATION 0.4
0.2 opioids
STANDARD_DEVIATION 0.4
0.1 opioids
STANDARD_DEVIATION 0.3
Mean number of pain medications1.2 medication
STANDARD_DEVIATION 0.9
1.1 medication
STANDARD_DEVIATION 0.9
1.0 medication
STANDARD_DEVIATION 0.9
1.1 medication
STANDARD_DEVIATION 1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
22 Participants56 Participants16 Participants18 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
42 Participants134 Participants47 Participants45 Participants
Region of Enrollment
United States
64 participants190 participants63 participants63 participants
Sex: Female, Male
Female
10 Participants29 Participants11 Participants8 Participants
Sex: Female, Male
Male
54 Participants161 Participants52 Participants55 Participants
Short Physical Performance Battery6.1 units on a scale
STANDARD_DEVIATION 1.9
6.1 units on a scale
STANDARD_DEVIATION 1.7
6.2 units on a scale
STANDARD_DEVIATION 1.5
6.1 units on a scale
STANDARD_DEVIATION 1.8
Timed stair climb14.5 seconds
STANDARD_DEVIATION 7.8
13.6 seconds
STANDARD_DEVIATION 6.6
13.9 seconds
STANDARD_DEVIATION 7.3
12.5 seconds
STANDARD_DEVIATION 4.7
Timed Up and Go13.1 seconds
STANDARD_DEVIATION 3.8
13.1 seconds
STANDARD_DEVIATION 4.7
13.9 seconds
STANDARD_DEVIATION 6.9
12.3 seconds
STANDARD_DEVIATION 3.4
WOMAC9.9 units on a scale
STANDARD_DEVIATION 4
9.8 units on a scale
STANDARD_DEVIATION 3.6
10.6 units on a scale
STANDARD_DEVIATION 3.6
9.0 units on a scale
STANDARD_DEVIATION 3.2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
3 / 630 / 641 / 63
serious
Total, serious adverse events
3 / 631 / 641 / 63

Outcome results

Primary

Pain (WOMAC)

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales: Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)

Time frame: 9 months following baseline

ArmMeasureValue (MEAN)Dispersion
Arm 1Pain (WOMAC)6.1 units on a scaleStandard Error 3.5
Arm 2Pain (WOMAC)6.6 units on a scaleStandard Error 3.6
Arm 3Pain (WOMAC)7.9 units on a scaleStandard Error 7.7

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026